Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • JD vs GSK✓SelectedUSD · GSKJD vs GSK performance historyLatest closeAs of+2.89%11/19
Stock and ETF performance explorer

JD vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+12.6%
GSK return
+97.7%
Excess return
-85.1%
Maximum drawdown
-79.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+2.9%-1.6%+4.5%+3.4%
7D-6.7%-4.7%-2.0%-5.1%
30D-4.2%-4.7%+0.5%-2.6%
3M-12.6%-8.8%-3.9%-10.0%
6M-20.8%-4.6%-16.2%-20.1%
YTD-7.5%+1.0%-8.5%-9.1%
1Y-8.0%+6.9%-14.9%-11.6%
3Y+1.8%+52.5%-50.7%-17.5%
5Y-68.0%+40.3%-108.3%-73.6%
All+12.6%+97.7%-85.1%-17.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling